Physician profile
Jennifer Lynn Monical
NPI 1740734078
$1,874.70
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Women'S Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $598 · 2022: $637 · 2023: $134 · 2024: $322 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $695.17 | 2021-2024 | Interstim |
| Revance Therapeutics, INC. | $385.47 | 2024-2025 | Daxxify |
| Abbvie INC. | $144.98 | 2021-2024 | |
| Allergan, INC. | $125.01 | 2022 | |
| Novo Nordisk INC | $121.94 | 2021 | |
| Astellas Pharma US INC | $120.98 | 2021-2022 | |
| Axonics, INC. | $51.81 | 2022-2023 | Axonics |
| Galderma Laboratories, L.P. | $51.21 | 2022-2025 | |
| Evofem Biosciences, INC. | $44.24 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $39.85 | 2021 | |
| Sumitomo Pharma America, INC. | $38.50 | 2024-2025 | Myfembree |
| Pfizer INC. | $25.83 | 2024 | |
| Organon LLC | $17.98 | 2022 | |
| 180 Medical, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Monical listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.